Pilatus Biosciences Announces First Patient Dosed in Hong Kong Clinical Trial of PLT012 for Liver Cancer Expansion
For best results when printing this announcement, please click on link below: Pilatus Biosciences Announces First Patient Dosed in Hong Kong Clinical Trial of PLT012 for Liver Cancer Expansion Milestone marks expansion of PLT012 clinical study in Hong Kong and further accelerating global clinical development program ac